|
 |
|
|
| |
3SBio applies for NuPIAO phase I clinical trial with SFDA
 |
|
| 3SBio, a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products in China, has submitted its application for a Phase I clinical trial for NuPIAO to the Chinese SFDA |
|
 |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| Duke University, Jubilant to enter global R&D partnership
|
|
| Duke University has entered into a partnership with Jubilant Organosys' subsidiary Jubiliant Biosys to develop a multi-faceted partnership that will expedite translation of discoveries by Duke scientists into clinical therapies |
|
|
|
|
| |
|
|
| |
|
|
| |
| Tobira announces in vitro data of TBR-652 for treatment of HIV
|
|
| Tobira Therapeutics, a clinical stage biotechnology company announced results from an in vitro study evaluating TBR-652 in combination with lopinavir, darunavir, atazanavir, tenofovir, etravirine, raltegravir using the infectious replicative assay |
|
|
|
|
| |
| Scientists unlock secret to youthful skin
|
|
| The international team of scientists led by Dr Bruno Reversade from A*STARs IMB discovered that mutations in the PYCR1 gene cause a rare genetic condition which results in premature skin ageing, called wrinkly skin syndrome |
|
|
|
|
| More |
